Andere Sprachen Sol-Gel Technologies Ltd.

Aktien

A2JDHD

IL0011417206

SLGL

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 18.04.2024			% 5 Tage	% 1. Jan.
0.9001 ^USD	+5.04%		+7.09%	-18.54%

13.03.	Sol-Gel Technologies Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
29.02.	Sol-Gel Technologies Ltd. wählt Yuval Yanai als externen Direktor	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	01.04.
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	13.03.
Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	29.02.
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	30.11.
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	30.11.
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	28.11.
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	20.11.
Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board	20.11.
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	09.11.
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	30.08.23
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	10.08.23
Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors	27.07.23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	21.06.23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	14.06.23
Sol-Gel Technologies, Searchlight Pharma Sign Licensing Deals for 2 Dermatology Drugs	06.06.23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	06.06.23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO and EPSOLAY in Canada	06.06.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sol-Gel Technologies Ltd.

Aktien

A2JDHD

IL0011417206

SLGL

Andere Sprachen

Filter